Cited by 177Burkholderia infections and melioidosisTransplantation: Methods and OutcomesInfections and bacterial resistance

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis

Open access

Murray, Susan, Charbeneau, Jeffery, Marshall, Bruce C., LiPuma, John J.·2008·American Journal of Respiratory and Critical Care Medicine

DOI 10.1164/rccm.200712-1834oc

Open this paper in CoChat — free account Open PDF

Abstract

Rationale: Lung transplantation offers the only survival option for patients with cystic fibrosis (CF) with end-stage pulmonary disease. Infection with Burkholderia species is typically considered a contraindication to transplantation in CF. However, the risks posed by different Burkholderia species on transplantation outcomes are poorly defined. Objectives: To quantify the risks of infection with Burkholderia species on survival before and after lung transplantation in patients with CF. Methods: Multivariate Cox survival models assessed hazard ratios of infection with Burkholderia species in 1,026 lung transplant candidates and 528 lung transplant recipients. Lung allocation scores, incorporating Burkholderia infection status, were calculated for transplant candidates. Measurements and Main Results: Transplant candidates infected with different Burkholderia species did not have statistically different mortality rates. Among transplant recipients infected with B. cenocepacia, only those infected with nonepidemic strains had significantly greater post-transplant mortality compared with uninfected patients (hazard ratio [HR], 2.52; 95% confidence interval [CI], 1.04–6.12; P = 0.04). Hazards were similar between uninfected transplant recipients and those infected with B. multivorans (HR, 0.66; 95% CI, 0.27–1.56; P = 0.34). Transplant recipients infected with B. gladioli had significantly greater post-transplant mortality than uninfected patients (HR, 2.23; 95% CI, 1.05–4.74; P = 0.04). Once hazards for species/strain were included, lung allocation scores of B. multivorans–infected transplant candidates were comparable to uninfected candidate scores, whereas those of candidates infected with nonepidemic B. cenocepacia or B. gladioli were lower. Conclusions: Post-transplant mortality among patients with CF infected with Burkholderia varies by infecting species. This variability should be taken into account in evaluating lung transplantation candidates.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1164/rccm.200712-1834oc

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Development of the New Lung Allocation System in the United States
Egan, T. M., Murray, S., Bustami, R. T., Shearon, T. H., McCullough, K. P., Edwards, L. B., Coke, M. A., Garrity, E. R., Sweet, S. C., Heiney, D. A., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01276.x · Cited by 767
Self-citation
DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III
Mahenthiralingam, E., Bischof, J. M., Byrne, S. K., Radomski, C. C. A., DAVIES, J. E., Av‐Gay, Y., & Vandamme, P. A. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3165-3173.2000 · Cited by 499
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
Hosenpud, J. D., Bennett, L. E., Keck, B. M., Edwards, E. B., & Novick, R. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06405-2 · Cited by 472
Lung Transplantation for Cystic Fibrosis Patients with Burkholderia cepacia Complex
Aris, R. M., ROUTH, J. C., LiPuma, J. J., Heath, D. G., & Gilligan, P. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2107022 · Cited by 255
Self-citation
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
Jones, A. M. (2004) · Thorax · doi:10.1136/thx.2003.017210 · Cited by 251
Infection with Burkholderia cepacia in Cystic Fibrosis
Chaparro, C., MAURER, J. R., GUTIERREZ, C., Krajden, M., CHAN, C., Winton, T. L., Keshavjee, S. H., Scavuzzo, M., Tullis, E. D., Hutcheon, M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.9811076 · Cited by 232
Update on the Burkholderia cepacia complex
LiPuma, J. J. (2005) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000181475.85187.ed · Cited by 217
Self-citation
Lung Transplantation and Survival in Children with Cystic Fibrosis
Liou, T. G., Adler, F. R., Cox, D. R., & Cahill, B. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066359 · Cited by 196

Flagged first, then by citations

Show all 40 references

Research works printed but not linked: 6

2007, Am J Transplant, 7, 244
1994, Curr Opin Pediatr, 6, 262
1997, J R Soc Med, 90, 59
1972, J Roy Stat Soc[Ser A], 34, 187
2000, Am J Respir Crit Care Med, 161, A720
2002, Microbiology, 149, 77

Sorted by citations

Items 101–176 of 176

Résultats de la transplantation pulmonaire
Quétant, S., Rochat, T., & Pison, C. M. (2010) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.08.001 · Cited by 12
Successful Use of Temocillin as Salvage Therapy for Cervical Osteomyelitis Secondary to Multidrug-Resistant Burkholderia cepacia
Rodriguez, M., Nelson, M., Kelly, J. E., Elward, A. M., & Morley, S. (2013) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pis110 · Cited by 12
“been considered an absolute contraindication to lung transplantation, and infection with some species may increase post-transplant mortality [2].”
Background
The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes
Mitchell, A. B., & Glanville, A. R. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1728797 · Cited by 12
Therapeutic approach to respiratory infections in lung transplantation
Clajus, C., Blasi, F., Welte, T., Greer, M., Fuehner, T., & Mantero, M. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.07.003 · Cited by 12
Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach
van den Bogaart, L., & Manuel, O. (2022) · Antibiotics · doi:10.3390/antibiotics11050612 · Cited by 11
“cenocepacia is the species associated with the highest antibiotic resistance and mortality rates, with a one-year survival rate in lung transplant recipients ranging from 37% to 60% [45,46].”
Background
Prognostic impact of preoperative respiratory colonization on early-onset pneumonia after lung transplantation
Kim, T., Yeo, H. J., Jang, J. H., Kim, D., Jeon, D., Kim, Y. S., & Cho, W. H. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1724 · Cited by 10
“To date, cystic fibrosis patients infected with Burkholderia cepacia are regarded as high risk for post-transplantation mortality (8).”
Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities
Dorgan, D. J., & Hadjiliadis, D. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.899906 · Cited by 10
“Other infections, including other Burkholderia species and M. abscessus, are difficult to treat but study results are conflicting, making it more difficult to assert firm conclusions.”
BackgroundInfluential
Enhancing care for individuals with advanced cystic fibrosis lung disease
Kapnadak, S. G., Ramos, K. J., & Dellon, E. P. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24937 · Cited by 10
Prophylactic phage biocontrol prevents Burkholderia gladioli infection in a quantitative ex planta model of bacterial virulence
Lauman, P., & Dennis, J. J. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.01317-24 · Cited by 9
Fatal Case ofBurkholderia gladioliPneumonia in a Patient With COVID-19
Rajendraprasad, S. S., Creech, Z. A., Truong, G. T., Nguyen, T. B., Addula, M., Mendoza, N., & Velagapudi, M. (2022) · Ochsner Journal · doi:10.31486/toj.22.0002 · Cited by 9
Post-transplant outcomes among cystic fibrosis patients undergoing lung transplantation colonized by Burkholderia: A single center cohort study
Gauvreau, A., Carrier, F. M., Poirier, C. D., Morisset, J., Lands, L. C., Lavoie, A., Nasir, B., Ferraro, P., & Luong, M. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.02.001 · Cited by 9
Update on Lung Transplantation for Cystic Fibrosis
Pilewski, J. M. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.07.002 · Cited by 8
Pulmonary Resection and Lung Transplantation for Bronchiectasis
Mauchley, D. C., Daley, C. L., Iseman, M. D., & Mitchell, J. D. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.04.001 · Cited by 8
A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure
Girgis, R. E., & Khaghani, A. (2016) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2016.5 · Cited by 7
Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel
Luong, M., Nakamachi, Y., Silveira, F. P., Morrissey, C. O., Danziger‐Isakov, L. A., Verschuuren, E. A. M., Wolfe, C. R., Hadjiliadis, D., Chambers, D. C., Patel, J. K., et al. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14251 · Cited by 6
A Phylogeny-Informed Proteomics Approach for Species Identification within the Burkholderia cepacia Complex
Wang, H., Cissé, O. H., Bolig, T. C., Drake, S. K., Chen, Y., Strich, J. R., Youn, J.-H., Okoro, U., Rosenberg, A. Z., Sun, J., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01741-20 · Cited by 5
“example, the identification of Burkholderia cenocepacia infection in cystic fibrosis lung 61 transplant recipients is associated with worse post-transplant survival compared to other Bcc 62 species(9, 10).”
BackgroundSelf-citation
Lungentransplantation
Fegbeutel, C., Gottlieb, J., Warnecke, G., & Haverich, A. (2014) · Der Pneumologe · doi:10.1007/s10405-014-0834-4 · Cited by 5
“Im Gegensatz dazu stellt die Besiedelung mit Burkholderia cenocepacia (Genomovar III) ein hohes Risiko für tödlich verlaufende Infektionen nach der Transplantation dar, weswegen diese Spezies in vielen Zentren als Kontraindikation angesehen wird [5].”
Factors Affecting Prognosis and Prediction of Outcome in Cystic Fibrosis Lung Disease
McCarthy, C., O’Carroll, O., Franciosi, A. N., & McElvaney, N. G. (2015) · InTech eBooks · doi:10.5772/60899 · Cited by 5
“Cenocepacia cohort and carriers of Burkholderia Gladioli, an organism not included in the BCC group, and generally considered less relevant as a CF pathogen [69].”
Background
Lung Transplantation in Cystic Fibrosis Patients in the Czech Republic: Initial Single-Center Experience
Bartakova, L. V., Fila, L., Adámek, S., Pozniak, J., Malý, M., Burkert, J., Šimonek, J., & Lischke, R. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.09.007 · Cited by 5
Disease-specific approach to lung transplantation
Knoop, C., & Estenne, M. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283303607 · Cited by 5
Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia
Vanhoutte, B., Cappoen, D., Maira, B. D. M., Cools, F., Torfs, E., Coenye, T., Martinet, W., Caljon, G., Maes, L. J. R. M., Delputte, P., et al. (2017) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2017.06.003 · Cited by 4
Lungentransplantation
Fuehner, T., Welte, T., & Gottlieb, J. (2012) · Der Internist · doi:10.1007/s00108-012-3020-y · Cited by 4
Cystic Fibrosis: From Qualification to Lung Transplantation, a Single Center Experience
Ochman, M., Latos, M., Urlik, M., Stącel, T., Nęcki, M., Tatoj, Z., Zawadzki, F., Wajda-Pokrontka, M., Przybyłowski, P., & Zembala, M. (2019) · Annals of Transplantation · doi:10.12659/aot.914328 · Cited by 4
Treatment of pulmonary exacerbations in cystic fibrosis
Smith, D. B., Reid, D. W., & Bell, S. C. (2011) · Therapy · doi:10.2217/thy.11.77 · Cited by 4
Cystic fibrosis: candidate selection and impact of the cystic fibrosis transmembrane conductance regulator therapy
Lehr, C. J., & Pilewski, J. M. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000975 · Cited by 4
Pretransplant screening for infections in lung and heart transplant candidates
Riunga, F., Cervera, C., & Kabbani, D. (2025) · JHLT Open · doi:10.1016/j.jhlto.2025.100409 · Cited by 3
“34, 35 For this reason, isolation of B. cenocepacia is a contraindication to LTx in many centres.”
Pediatric Lung Transplantation
Sweet, S. C., & Noyes, B. E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1984-0.00064-4 · Cited by 3
Gram-Negative Bacterial Infections After Hematopoietic Stem Cell or Solid Organ Transplantation
Averbuch, D., & Engelhard, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_21 · Cited by 3
A Burkholderia phage selects for attenuated virulence and antimicrobial hypersensitivity through increased outer membrane permeability
Lauman, P., Hussain, N. A. S., Stafford, J. L., & Dennis, J. J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1876186 · Cited by 2
“…high intrinsic resistance to many antimicrobials, and infection with this pathogen is often considered a contraindication for lung transplantation, leaving affected patients with few therapeutic options (Murray et al., 2008; Segonds et al., 2009; Dursun et al., 2012; Somayaji et al., 2020).”
pErFil microbiológico na FibrosE cística
Marques, E. A. (2011) · Cited by 2
Lung and heart-lung transplantation
Date, H., & Sweet, S. C. (2009) · Cardiology in the Young · doi:10.1017/s1047951109003953 · Cited by 2
The course of cystic fibrosis in adult patients with Burkholderia cepacia complex infection
Afanaseva, M. V., Krasovskiy, S., & Amelina, E. (2025) · PULMONOLOGIYA · doi:10.18093/0869-0189-2025-35-2-241-253 · Cited by 1
The phospholipase PlcP mediates membrane lipid remodeling required for the intracellular survival of Burkholderia cenocepacia
Shropshire, H., Han, X., Han, Z., Clough, B., Jones, R. A., Ahmed, S., García‐Romero, I., Aberdeen, I., Ghosh, P., Nezis, I. P., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113600 · Cited by 1
“However, Bcc infections are problematic due to the high-level intrinsic resistance of Burkholderia species to antimicrobials (6, 7), and the transmissibility of the infection across patients (8, 9); thus, such infections are a contraindication to lung transplantation (10, 11).”
Najczęstsze zakażenia przeszczepionych płuc
Korzeniewska, A., Dyła, T., Kosacka, M., & Jankowska, R. (2009) · Advances in respiratory medicine · doi:10.5603/arm.27795 · Cited by 1
Multidrug-Resistant Organisms in Solid Organ Transplantation
Rana, M. M., Grossi, P., & Huprikar, S. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-15394-6_11 · Cited by 1
Antimicrobial Stewardship: Considerations for a Transplant Center
Seo, S. K., & Forrest, G. N. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_59 · Cited by 1
Pediatric Lung Transplantation
Potera, R. M., & Huddleston, C. B. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6359-6_28 · Cited by 1
Cystic Fibrosis
Donaldson, S. H., Wolfgang, M. C., Gilligan, P. H., & Boucher, R. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00068-0 · Cited by 1
Successful Bridge to Lung Transplant in a Patient With Cystic Fibrosis Colonized With Pan-Resistant Burkholderia Multivorans
Moneke, I., & Kalbhenn, J. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.09.002 · Cited by 1
Burkholderia in Transplant: Important to Speciate and Important to Treat
Snell, G. I., Smibert, O. C., & Tullis, E. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_22-1 · Cited by 1
Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors
Nanayakkara, D. D., & Schaenman, J. M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_9-1 · Cited by 1
Emerging Transplant Infections: Cystic Fibrosis
Mohamedaly, O. H., & Johnson, C. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_60 · Cited by 1
Surveillance Cultures
Leber, A. L. (2016) · ASM Press eBooks · doi:10.1128/9781555818814.ch13.6.1 · Cited by 1
Burkholderia , Stenotrophomonas , Ralstonia , Cupriavidus , Pandoraea , Brevundimonas , Comamonas , Delftia , and Acidovorax
LiPuma, J. J., Currie, B. J., Baird, R., & Vandamme, P. A. R. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0046 · Cited by 1
Self-citation
Lung transplantation programme in Croatia
Samaržija, M., Redžepi, G., Klepetko, W., & Jakopović, M. (2015) · Hrčak Portal of scientific journals of Croatia (University Computing Centre)
Update to the guidelines for selection of lung-transplant candidates
Silhan, L. L., & Orens, J. B. (2014) · Current Respiratory Care Reports · doi:10.1007/s13665-014-0078-0
“cepacia genomovar III) have had exceedingly worse outcomes, although strain-specific variations exist [40, 41].”
Background
Identificação de bactérias não fermentadoras isoladas de pacientes com fibrose cística e em hemoculturas de pacientes internados no HC da Unicamp
Filho, É. B. D. C. (2015) · doi:10.47749/t/unicamp.2015.946412
Lung Transplantation in a Patient with Pre-transplant Colonization of Extensively Drug-resistant Acinetobacter baumannii
Lee, H. Y., Lee, H., Shin, S. B., Shin, K. S., Lee, B. W., Kim, H. W., Lee, S., & Kim, S. C. (2015) · The Korean Journal of Critical Care Medicine · doi:10.4266/kjccm.2015.30.2.103
Fibrose quistica: indicações para transplantes pulmonar e avaliação dos resultados.
de Almeida, M. I. G., & Sánchez, S. (2011)
Microbiological and epidemiological features of clinical respiratory isolates of 2
Segonds, C., Clavel-Batut, P., Thouverez, M., Grenet, D., Alain, Plésiat, P., & Chabanon, G. (2009)
Timing of Listing and Patient Management on the Waiting List
Visner, G. A., Schecter, M. G., & Sweet, S. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-08049-9_64-1
Indications for Lung Transplantation
Josephson, M. B., Benden, C., & Hanna, B. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-08049-9_63-1
Pretransplant Considerations in Patients with Obstructive Lung Disease: COPD, Lymphangioleiomyomatosis, Cystic Fibrosis, and Non-CF Bronchiectasis
Ajani, S., & Kotloff, R. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-91184-7_3
Prevention and Treatment Regimens for Non-viral Infections in the Lung Transplant Recipient
Zamora, M. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-91184-7_14
Pediatric Lung Transplantation
Blatter, J. A., Noyes, B. E., & Sweet, S. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00067-5
Postoperative Complications and Management
Pasero, D., Lees, N. J., Costamagna, A., Ellena, M., Montrucchio, G. G., & Brazzi, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-40679-0_81
Indications and Contraindications in Lung Transplantation
Slama, A., & Aigner, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-40679-0_78
Emerging Transplant Infections: Cystic Fibrosis
Mohamedaly, O. H., & Johnson, C. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_60-1
Risk Factors for Oral Antibiotic Therapy Failure in Cystic Fibrosis-related Pulmonary Exacerbations
Blanchard, A. C. (2019) · TSpace (University of Toronto)
Current World Literature
(2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283328a80
Lung Transplantation: Recipient Selection
Glanville, A. R., & Ainge‐Allen, H. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00082-2
Lung and Heart Lung Transplantation
Sweet, S. C., & Huddleston, C. B. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_135
Lung Transplantation for Cystic Fibrosis
Pilewski, J. M. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_12
Lung Transplantation for Cystic Fibrosis
Merlo, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00263-8
Burkholderia in Transplant: Important to Speciate and Important to Treat
Snell, G. I., Smibert, O. C., & Tullis, E. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_22
Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors
Nanayakkara, D. D., & Schaenman, J. M. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_9
Timing of Listing and Patient Management on the Waiting List
Visner, G. A., Schecter, M. G., & Sweet, S. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-07284-5_64
Indications for Lung Transplantation
Josephson, M. B., Benden, C., & Hanna, B. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-07284-5_63
Glyceroglycolipids are essential for Burkholderia cenocepacia intracellular survival by preventing phagolysosome acidificationPreprint
Shropshire, H., Guillonneau, R., Han, Z., Jones, R. A., Ahmed, S., García‐Romero, I., Aberdeen, I., Nezis, I. P., Valvano, M. A., Scanlan, D. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.30.542800
Dealing with Difficult Bugs Before Lung Transplantation
Mehta, N., Lyon, G. M., & Pouch, S. M. (2024) · Organ and tissue transplantation · doi:10.1007/978-3-319-20788-9_16-1
Dealing with Difficult Bugs Before Lung Transplantation
Mehta, N., Lyon, G. M., & Pouch, S. M. (2024) · Organ and tissue transplantation · doi:10.1007/978-3-030-36123-5_16
Burkholderia , Stenotrophomonas , Ralstonia , Cupriavidus , Pandoraea , Brevundimonas , Comamonas , Delftia , and Acidovorax
LiPuma, J. J., Currie, B. J., Baird, R., & Vandamme, P. A. R. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0046
Self-citation
Surveillance Cultures for Hospital‐Associated Infections
Gumbis, S., Aubert, R. D., Sievert, D. M., Lainhart, W., Pitout, J. D. D., Bibby, H. L., Bourassa‐Blancette, S., Lockhart, S. R., Green, D. A., Imlay, H. N., et al. (2023) · ClinMicroNow · doi:10.1002/9781683670438.cmph0163
Régulation de l'activité de la protéine du surfactant SP-A par les cathepsines à cystéine pulmonaires : conséquences sur les propriétés antibactériennes de SP -A.
Naudin, C. (2011) · theses.fr (ABES) · doi:10.70675/145edc17za90ez4d10z9343zea2b4521ef40
Microbiotes Pulmonaires des patients atteints de mucoviscidose : interactions avec Pseudomonas aeruginosa
Pagès, L. (2016) · theses.fr (ABES) · doi:10.70675/9d450abbzb581z49cez9268z17379d9c31b5
Pregnancy in females with cystic fibrosis and chronic Burkholderia cepacia complex or non-tuberculous mycobacteria infection: A single centre case series
Downes, A., Weitnauer, L., Robinson, R., Barakat, S., Bowman, E., Williamson, C., Jones, A., Simmonds, N. J., Scott, R., & Felton, I. C. (2026) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666261493710

Authors: Murray, S., Charbeneau, J., Marshall, B. C., & LiPuma, J. J.
Affiliations: University of Michigan (US)
Cystic Fibrosis Foundation (US)
ORCID: Murray, Susan
LiPuma, John J.
Venue: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Published: 2008-08
Volume: 178
Issue: 4
Pages: 363-371
ISSN: 1073-449X (ISSN-L)
1535-4970
DOI: 10.1164/rccm.200712-1834oc
OpenAlex: W2081925747
Semantic Scholar: 68cf39ee60f9774eb35ae3f703478d0c836ebf29
Cited by: 177
References: 40
Citations by year: 2026: 3 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 9 · 2017: 12 · 2016: 9 · 2015: 13 · 2014: 14 · 2013: 8 · 2012: 12
FWCI: 10.54
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: American Journal of Respiratory and Critical Care Medicine (publishedVersion)
PubMed (publishedVersion)
Deep Blue (University of Michigan) (submittedVersion)
Funders: U.S. Department of Health and Human Services
Cystic Fibrosis Foundation
Health Resources and Services Administration
Topics: Health Sciences › Medicine › Epidemiology › Burkholderia infections and melioidosis
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
Keywords: cystic fibrosis, lung transplantation, Burkholderia cenocepacia, Burkholderia multivorans, Burkholderia gladioli, post-transplant mortality, lung allocation score, transplant candidates
MeSH terms: Contraindications, Adult, Cystic Fibrosis, Female, Humans, Male, Postoperative Complications, Prognosis, Risk, United States, Cohort Studies, Survival Rate, Multivariate Analysis, Case-Control Studies, Lung Transplantation, Treatment Outcome, Pneumonia, Bacterial, Disease-Free Survival, Burkholderia Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks